| Dr Harry Alan Hamburger, MD MS | |
|
3280 Old Boynton Rd, Boynton Beach, FL 33436-6506 | |
| (561) 733-3010 | |
| (561) 733-0039 |
| Full Name | Dr Harry Alan Hamburger |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 45 Years |
| Location | 3280 Old Boynton Rd, Boynton Beach, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396834883 | NPI | - | NPPES |
| 058392800 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | ME0041250 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Retina Macula Specialists Of Miami Llc | 7012156144 | 22 |
News Archive
Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceutical products announced the addition of customized Formulation Development to the company's platform of services, which will be overseen by the newly appointed Dr. James Matsuura, Director of Formulation Development.
A healthy system of gut bacteria, or microbiota, is crucial to health: Gut bacteria not only aid with digestion, but also play an important role in the body's immune response. Infants, however, are not born with full-fledged gut microbiota, which makes it difficult for them to fight off intestinal infections.
Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration granted final approval for the Company's Abbreviated New Drug Application for levofloxacin ophthalmic solution, 0.5% the generic for Vistakon's Quixin ophthalmic solution, which had sales of $2 million for the 12 months ended December 2010 according to IMS sales data.
Georgia State University's H. Elliott Albers, the Regents' Professor of Neuroscience and director of the Center for Behavioral Neuroscience, has received a four-year, $1.3 million grant from the National Institutes of Health to study how the body's internal clock is "reset," a key to understanding more about sleep and other disorders affecting human health.
› Verified 7 days ago
| Entity Name | Michael L. Levine Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205120110 PECOS PAC ID: 9032381496 Enrollment ID: O20111006000303 |
News Archive
Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceutical products announced the addition of customized Formulation Development to the company's platform of services, which will be overseen by the newly appointed Dr. James Matsuura, Director of Formulation Development.
A healthy system of gut bacteria, or microbiota, is crucial to health: Gut bacteria not only aid with digestion, but also play an important role in the body's immune response. Infants, however, are not born with full-fledged gut microbiota, which makes it difficult for them to fight off intestinal infections.
Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration granted final approval for the Company's Abbreviated New Drug Application for levofloxacin ophthalmic solution, 0.5% the generic for Vistakon's Quixin ophthalmic solution, which had sales of $2 million for the 12 months ended December 2010 according to IMS sales data.
Georgia State University's H. Elliott Albers, the Regents' Professor of Neuroscience and director of the Center for Behavioral Neuroscience, has received a four-year, $1.3 million grant from the National Institutes of Health to study how the body's internal clock is "reset," a key to understanding more about sleep and other disorders affecting human health.
› Verified 7 days ago
| Entity Name | Inna Ozerov Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568723476 PECOS PAC ID: 3577719061 Enrollment ID: O20120816000493 |
News Archive
Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceutical products announced the addition of customized Formulation Development to the company's platform of services, which will be overseen by the newly appointed Dr. James Matsuura, Director of Formulation Development.
A healthy system of gut bacteria, or microbiota, is crucial to health: Gut bacteria not only aid with digestion, but also play an important role in the body's immune response. Infants, however, are not born with full-fledged gut microbiota, which makes it difficult for them to fight off intestinal infections.
Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration granted final approval for the Company's Abbreviated New Drug Application for levofloxacin ophthalmic solution, 0.5% the generic for Vistakon's Quixin ophthalmic solution, which had sales of $2 million for the 12 months ended December 2010 according to IMS sales data.
Georgia State University's H. Elliott Albers, the Regents' Professor of Neuroscience and director of the Center for Behavioral Neuroscience, has received a four-year, $1.3 million grant from the National Institutes of Health to study how the body's internal clock is "reset," a key to understanding more about sleep and other disorders affecting human health.
› Verified 7 days ago
| Entity Name | Hollywood Eye Institute,pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407102247 PECOS PAC ID: 0143475632 Enrollment ID: O20130307000315 |
News Archive
Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceutical products announced the addition of customized Formulation Development to the company's platform of services, which will be overseen by the newly appointed Dr. James Matsuura, Director of Formulation Development.
A healthy system of gut bacteria, or microbiota, is crucial to health: Gut bacteria not only aid with digestion, but also play an important role in the body's immune response. Infants, however, are not born with full-fledged gut microbiota, which makes it difficult for them to fight off intestinal infections.
Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration granted final approval for the Company's Abbreviated New Drug Application for levofloxacin ophthalmic solution, 0.5% the generic for Vistakon's Quixin ophthalmic solution, which had sales of $2 million for the 12 months ended December 2010 according to IMS sales data.
Georgia State University's H. Elliott Albers, the Regents' Professor of Neuroscience and director of the Center for Behavioral Neuroscience, has received a four-year, $1.3 million grant from the National Institutes of Health to study how the body's internal clock is "reset," a key to understanding more about sleep and other disorders affecting human health.
› Verified 7 days ago
| Entity Name | Retina Macula Specialists Of Miami Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982946612 PECOS PAC ID: 7012156144 Enrollment ID: O20130620000268 |
News Archive
Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceutical products announced the addition of customized Formulation Development to the company's platform of services, which will be overseen by the newly appointed Dr. James Matsuura, Director of Formulation Development.
A healthy system of gut bacteria, or microbiota, is crucial to health: Gut bacteria not only aid with digestion, but also play an important role in the body's immune response. Infants, however, are not born with full-fledged gut microbiota, which makes it difficult for them to fight off intestinal infections.
Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration granted final approval for the Company's Abbreviated New Drug Application for levofloxacin ophthalmic solution, 0.5% the generic for Vistakon's Quixin ophthalmic solution, which had sales of $2 million for the 12 months ended December 2010 according to IMS sales data.
Georgia State University's H. Elliott Albers, the Regents' Professor of Neuroscience and director of the Center for Behavioral Neuroscience, has received a four-year, $1.3 million grant from the National Institutes of Health to study how the body's internal clock is "reset," a key to understanding more about sleep and other disorders affecting human health.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Harry Alan Hamburger, MD MS 3280 Old Boynton Rd, Boynton Beach, FL 33436-6506 Ph: (561) 733-3010 | Dr Harry Alan Hamburger, MD MS 3280 Old Boynton Rd, Boynton Beach, FL 33436-6506 Ph: (561) 733-3010 |
News Archive
Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceutical products announced the addition of customized Formulation Development to the company's platform of services, which will be overseen by the newly appointed Dr. James Matsuura, Director of Formulation Development.
A healthy system of gut bacteria, or microbiota, is crucial to health: Gut bacteria not only aid with digestion, but also play an important role in the body's immune response. Infants, however, are not born with full-fledged gut microbiota, which makes it difficult for them to fight off intestinal infections.
Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration granted final approval for the Company's Abbreviated New Drug Application for levofloxacin ophthalmic solution, 0.5% the generic for Vistakon's Quixin ophthalmic solution, which had sales of $2 million for the 12 months ended December 2010 according to IMS sales data.
Georgia State University's H. Elliott Albers, the Regents' Professor of Neuroscience and director of the Center for Behavioral Neuroscience, has received a four-year, $1.3 million grant from the National Institutes of Health to study how the body's internal clock is "reset," a key to understanding more about sleep and other disorders affecting human health.
› Verified 7 days ago
Miss Elizabeth Oteiza, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 901 N Congress Ave, Suite 104, Boynton Beach, FL 33426 Phone: 561-732-8005 Fax: 561-732-0150 | |
Dr. Garry Joseph Thomas, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1901 S Congress Ave, Suite 300, Boynton Beach, FL 33426 Phone: 561-602-7773 Fax: 561-336-2267 | |
Dr. Laura Rubinate, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 11195 S Jog Rd # 1&2, Boynton Beach, FL 33437 Phone: 561-752-0075 | |
Dr. Deval Dinesh Joshi, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10075 S Jog Rd, Suite 203, Boynton Beach, FL 33437 Phone: 561-767-9999 Fax: 855-699-3535 | |
Dr. Stephen Marc Robins, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10301 Hagen Ranch Rd Ste 500, Boynton Beach, FL 33437 Phone: 561-737-4040 Fax: 561-369-7104 | |
Dr. Jay R. Pechter, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1880 N Congress Ave, Suite 309, Boynton Beach, FL 33426 Phone: 561-733-2388 | |
Dr. Lee Scott Friedman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1717 W Woolbright Rd, Boynton Beach, FL 33426 Phone: 561-737-5500 Fax: 561-737-7055 |